| Dr Richard Francis Ambrose Jr, DPM | |
|
415 Mill Rd, Adrian, MI 49221-1764 | |
| (734) 425-4000 | |
| (517) 263-0427 |
| Full Name | Dr Richard Francis Ambrose Jr |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 415 Mill Rd, Adrian, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861444796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 0001007 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Francis Ambrose Jr, DPM 16170 Franklin Rd, Northville, MI 48168-9515 Ph: (517) 263-0427 | Dr Richard Francis Ambrose Jr, DPM 415 Mill Rd, Adrian, MI 49221-1764 Ph: (734) 425-4000 |
News Archive
Rhesus macaques that were vaginally infected with Zika virus showed higher prevalence of Zika in the reproductive tract than previously seen in macaques that received skin injections of the virus.
Surgical patients who receive antibiotics before certain types of low-risk operations are not at an increased risk for antibiotic-resistant infections immediately after their procedures, according to results from a large-scale study conducted by researchers from Columbia University Medical Center, New York City.
Myotec Therapeutics, Ltd. and Hybrid BioSystems, Ltd. today announced their merger to form PsiOxus Therapeutics, Ltd. (PsiOxus), a new, development stage biotechnology company using non-traditional approaches to novel therapeutics for cancer and wasting diseases. PsiOxus, which will be led by CEO Dr. John Beadle, boasts a combined pipeline of phase I and II clinical stage assets.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.
› Verified 7 days ago
Richard F Ambrose Jr Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 415 Mill Rd, Adrian, MI 49221 Phone: 517-263-0427 | |
Dr Martins Foot And Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 1325 N Main St, Adrian, MI 49221 Phone: 517-879-4242 Fax: 517-879-4240 | |
Podiatric Surgeons Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 324 E Maumee St, Adrian, MI 49221 Phone: 517-265-3307 Fax: 517-263-5003 | |
Dr. Timothy Blackerby, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5415 Treat Hwy, Adrian, MI 49221 Phone: 517-263-5813 | |
Christopher Donald Valkier, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 770 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0650 | |
Dr Martins Foot And Ankle Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1325 N Main St Ste C, Adrian, MI 49221 Phone: 517-879-4241 |